This leads to constitutive activation of KRAS and upregulation of downstream signaling cascades that promote many of the hallmarks of cancer, including sustained proliferation [6], metabolic reprogramming [7], resistance to apoptosis [8], immunological escape [9–11], cell migration [12], and metastasis [13, 14]. The gene discussed is KRAS; the disease is cancer.